Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants
Authors
Keywords
-
Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 114, Issue 1, Pages 51-68
Publisher
Wiley
Online
2023-04-10
DOI
10.1002/cpt.2903
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic Drug Monitoring of Antidepressants: An Underused but Potentially Valuable Tool in Primary Care
- (2022) Daria Piacentino et al. Frontiers in Psychiatry
- Impact of the novel CYP2C:TG haplotype and CYP2B6 variants on sertraline exposure in a large patient population
- (2022) Line Skute Bråten et al. CTS-Clinical and Translational Science
- Pharmacogenomic Testing and Depressive Symptom Remission: A Systematic Review and Meta‐Analysis of Prospective, Controlled Clinical Trials
- (2022) Lisa C. Brown et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Cost Effectiveness of Pharmacogenetic Testing for Drugs with Clinical Pharmacogenetics Implementation Consortium ( CPIC ) Guidelines: A Systematic Review
- (2022) Sarah A. Morris et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A longitudinal study of cytochrome P450 2D6 (CYP2D6) activity during adolescence
- (2022) J. Steven Leeder et al. CTS-Clinical and Translational Science
- PharmVar GeneFocus: CYP2B6
- (2021) Zeruesenay Desta et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy
- (2021) Sony Tuteja et al. CTS-Clinical and Translational Science
- Serotonin Transporter Genetic Variation and Antidepressant Response and Tolerability: A Systematic Review and Meta-Analysis
- (2021) Kiera Stein et al. Journal of Personalized Medicine
- PharmVar GeneFocus: CYP2C19
- (2020) Mariana R. Botton et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenetic association of bi- and triallelic polymorphisms of SLC6A4 with antidepressant response in major depressive disorder
- (2020) Feifei Ren et al. JOURNAL OF AFFECTIVE DISORDERS
- Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review
- (2020) Sylvia D. Klomp et al. Journal of Clinical Medicine
- PharmVar GeneReview: CYP2D6
- (2019) Charity Nofziger et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Standardizing CYP 2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group
- (2019) Kelly E. Caudle et al. CTS-Clinical and Translational Science
- Pharmacogenetics and therapeutic drug monitoring of fluoxetine in a real-world setting: A PK/PD analysis of the influence of (non-)genetic factors.
- (2019) Paulo Magalhães et al. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
- Antidepressant Tolerability in Pediatric Anxiety and Obsessive-Compulsive Disorders: A Bayesian Hierarchical Modeling Meta-Analysis
- (2019) Jeffrey A. Mills et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- The Impact of Antidepressant Dose and Class on Treatment Response in Pediatric Anxiety Disorders: A Meta-Analysis
- (2018) Jeffrey R. Strawn et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Genotype, phenotype, and medication recommendation agreement among commercial pharmacogenetic-based decision support tools
- (2018) Chad A. Bousman et al. PHARMACOGENOMICS JOURNAL
- Genotype-sensitive reversible and time-dependent CYP2D6 inhibition in human liver microsomes
- (2018) Flavia Storelli et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Standardized Biogeographic Grouping System for Annotating Populations in Pharmacogenetic Research
- (2018) Rachel Huddart et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials
- (2018) Chad A Bousman et al. PHARMACOGENOMICS
- A comparative study of QT prolongation with serotonin reuptake inhibitors
- (2017) Ana Ojero-Senard et al. PSYCHOPHARMACOLOGY
- Raising the Minimum Effective Dose of Serotonin Reuptake Inhibitor Antidepressants
- (2016) Daniel J. Safer JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Looking Beyond the 5-HTTLPR Polymorphism: Genetic and Epigenetic Layers of Regulation Affecting the Serotonin Transporter Gene Expression
- (2016) Sandra Iurescia et al. MOLECULAR NEUROBIOLOGY
- Population Frequencies of the Triallelic 5HTTLPR in Six Ethnicially Diverse Samples from North America, Southeast Asia, and Africa
- (2015) Brett C. Haberstick et al. BEHAVIOR GENETICS
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline forCYP2D6andCYP2C19Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors
- (2015) JK Hicks et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Role of the 5-HTTLPR and SNP Promoter Polymorphisms on Serotonin Transporter Gene Expression: a Closer Look at Genetic Architecture and In Vitro Functional Studies of Common and Uncommon Allelic Variants
- (2015) Sandra Iurescia et al. MOLECULAR NEUROBIOLOGY
- A Comparison of the Risk of QT Prolongation Among SSRIs
- (2014) Kylee A. Funk et al. ANNALS OF PHARMACOTHERAPY
- Population Pharmacokinetic Meta-Analysis of Vortioxetine in Healthy Individuals
- (2014) Johan Areberg et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Emergency Department Visits by Adults for Psychiatric Medication Adverse Events
- (2014) Lee M. Hampton et al. JAMA Psychiatry
- Pharmacogenetics in major depression: A comprehensive meta-analysis
- (2013) Tomihisa Niitsu et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Multiple Regulatory Variants Modulate Expression of 5-Hydroxytryptamine 2A Receptors in Human Cortex
- (2012) Ryan M. Smith et al. BIOLOGICAL PSYCHIATRY
- Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function
- (2012) J C Stingl et al. MOLECULAR PSYCHIATRY
- CYP2C19 genotype predicts steady state escitalopram concentration in GENDEP
- (2011) Patricia Huezo-Diaz et al. JOURNAL OF PSYCHOPHARMACOLOGY
- AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011
- (2011) C. Hiemke et al. PHARMACOPSYCHIATRY
- Human hepatic CYP2B6 developmental expression: The impact of age and genotype
- (2009) Edward L. Croom et al. BIOCHEMICAL PHARMACOLOGY
- CYP2D6 and ABCB1 Genetic Variability: Influence on Paroxetine Plasma Level and Therapeutic Response
- (2009) Marianne Gex-Fabry et al. THERAPEUTIC DRUG MONITORING
- Serum concentrations of sertraline and N-desmethyl sertraline in relation to CYP2C19 genotype in psychiatric patients
- (2008) I. Rudberg et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now